Vernon Hills, IL, United States of America

Yi Gao

This inventor holds 23 USPTO granted patents and 19 published patent applications, plus 9 CIPO patents and 15 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Pharma Cinq, LLC. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Gao. Retrieved from https://idiyas.com/inventor/yi-gao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 87.0

 

 

Average Co-Inventor Count = 11.7

ph-index = 6

Forward Citations = 120(Granted Patents)


Company Filing History:


Years Active: 2007-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antiviral Compounds
Solid Pharmaceutical Compositions
HCV Treatment
Pyrimidinedione Derivatives
Anti-Infective Agents
Solid Dosage Forms
Pharmaceutical Formulations
Kinase Inhibitors
Fenofibric Acid Salts
23 patents (USPTO):Explore Patents

Title: Innovations of Yi Gao in Pharmaceutical Sciences

Introduction

Yi Gao, a prominent inventor based in Vernon Hills, IL, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 22 patents. His innovative approach focuses on enhancing drug formulations, which has influenced the treatment of various health conditions, particularly those relating to hepatitis C virus (HCV).

Latest Patents

Among his latest patents, Yi Gao has developed solid pharmaceutical compositions aimed at effectively treating HCV. The invention includes a unique formulation comprising two distinct compounds. The first layer contains 100 mg of Compound 1 along with pharmaceutically acceptable hydrophilic polymers and surfactants, all formulated in an amorphous solid dispersion. The second layer features 40 mg of Compound 2, similarly integrating the necessary polymers and surfactants in amorphous solid dispersion. Another noteworthy patent involves the formulation of pyrimidinedione derivative compounds, addressing the methods of preparing these compounds and enhancing their bioavailability in pharmaceutical compositions, while also optimizing the quantity needed for the same therapeutic effect.

Career Highlights

Throughout his career, Yi Gao has collaborated with leading companies in the pharmaceutical sector, including AbbVie Inc. and Abbott Laboratories Corporation. His work at these organizations has been pivotal in advancing the development of new medical treatments, showcasing his expertise in pharmaceutical formulations and innovation.

Collaborations

Yi Gao has worked alongside notable colleagues such as Pamela L. Donner and Allan C. Krueger. Their collaborative efforts have further propelled advancements in pharmaceutical sciences, enhancing the scope of research and development in the industry.

Conclusion

Yi Gao's contributions through his patents demonstrate a dedicated pursuit of innovation in pharmaceuticals. His work not only reflects his expertise but also significantly impacts the availability of effective treatments for patients worldwide. With a growing number of patents and ongoing research, Yi Gao remains a key figure in the realm of pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…